Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

Abroad (travel likely)RecruitingPHASE1

Conditions

Liver Cancer · Rhabdomyosarcoma · Malignant Rhabdoid Tumor · Liposarcoma · Wilms Tumor · Yolk Sac Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Texas Children's Hospital, Houston, Texas, United States
Contact: Study coordinator (David Steffin, MD) · dhsteffi@texaschildrens.org · (832) 824-4233

Study leads

David Steffin, MD
Principal Investigator
Baylor College of Medicine

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

Metastatic Hepatocellular Carcinoma · Local Advanced Hepatocellular Carcinoma · Alpha-fetoprotein (AFP)-Producing Gastric Cancer

Abroad (travel likely)RecruitingPHASE1

Goodyear, United States · Duarte, United States

Effect and Mechanism of ALPPS Operation on Liver Regeneration

Hepato Cellular Carcinoma (HCC) · Hepatobiliary Cancers · Liver Cancer

Abroad (travel likely)Recruiting

Beijing, China

Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases

Hepatocellular Carcinoma · Liver Cancer Stage IV · Pulmonary Metastases

Abroad (travel likely)Recruiting

Guanzhou, China · Guanzhou, China